Your browser doesn't support javascript.
loading
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.
Fallet, Benedict; Foglierini, Mathilde; Porret, Raphael; Alcaraz-Serna, Ana; Sauvage, Christophe; Jenelten, Raphael; Caplanusi, Teofila; Gilliet, Michel; Perez, Laurent; Fenwick, Craig; Genolet, Raphael; Harari, Alexandre; Bobisse, Sara; Gottardo, Raphael; Pantaleo, Giuseppe; Muller, Yannick D.
Afiliação
  • Fallet B; Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland.
  • Foglierini M; Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland; Biomedical Data Science Center, University Hospital of Lausanne, Switzerland.
  • Porret R; Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland.
  • Alcaraz-Serna A; Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland.
  • Sauvage C; Center for Cell Immunotherapy, Department of Oncology and Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne CH-1066, Switzerland.
  • Jenelten R; Department of Dermatology and Venereology, University Hospital of Lausanne, Switzerland.
  • Caplanusi T; Department of Dermatology and Venereology, University Hospital of Lausanne, Switzerland.
  • Gilliet M; Department of Dermatology and Venereology, University Hospital of Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.
  • Perez L; Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.
  • Fenwick C; Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland.
  • Genolet R; Center for Cell Immunotherapy, Department of Oncology and Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne CH-1066, Switzerland.
  • Harari A; Center for Cell Immunotherapy, Department of Oncology and Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne CH-1066, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.
  • Bobisse S; Center for Cell Immunotherapy, Department of Oncology and Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne CH-1066, Switzerland.
  • Gottardo R; Biomedical Data Science Center, University Hospital of Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland; Swiss Institute for Bioinformatics, Lausanne, Switzerland.
  • Pantaleo G; Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland.
  • Muller YD; Division of Immunology and Allergy, University Hospital of Lausanne, Switzerland; University of Lausanne, Faculty of Biology and Medicine, Lausanne, Switzerland. Electronic address: Yannick.muller@chuv.ch.
J Infect ; 87(2): 111-119, 2023 08.
Article em En | MEDLINE | ID: mdl-37321353
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article